TPIDB > 臨床試驗主持人
臨床試驗主持人
發表文獻
76筆
71
Hsu YL, Chen CC, Lin YT, Wu WK, Chang LC, Lai CH, Wu MS, Kuo CH. Evaluation and Optimization of Sample Handling Methods for Quantification of Short-Chain Fatty Acids in Human Fecal Samples by GC-MS. J Proteome Res. 2019 May 3;18(5):1948-1957. doi: 10.1021/acs.jproteome.8b00536. Epub 2019 Apr 1. PMID: 30895795.
72
Tseng PH, K M Wong R, Wu MS. Reply to the letter "Measuring LES and UES basal pressure". Neurogastroenterol Motil. 2019 Mar;31(3):e13516. doi: 10.1111/nmo.13516. PMID: 30793840.
73
Yu LY, Hu KC, Liu CJ, Hung CL, Bair MJ, Chen MJ, Wang HY, Wu MS, Shih SC, Liu CC. Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaque. Medicine (Baltimore). 2019 Mar;98(9):e14672. doi: 10.1097/MD.0000000000014672. PMID: 30817593; PMCID: PMC6831312.
74
Yeo YH, Hsu CC, Lee CC, Ho HJ, Lin JT, Wu MS, Liou JM, Wu CY; Taiwan Gastrointestinal Disease and Helicobacter Consortium. Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication. J Gastroenterol Hepatol. 2019 Jan;34(1):59-67. doi: 10.1111/jgh.14462. Epub 2018 Oct 11. PMID: 30169908.
75
Liou JM, Lee YC, El-Omar EM, Wu MS. Efficacy and Long-Term Safety of H. pylori Eradication for Gastric Cancer Prevention. Cancers (Basel). 2019 Apr 28;11(5):593. doi: 10.3390/cancers11050593. PMID: 31035365; PMCID: PMC6562927.
76
Liu Z, Goldstein AM, Hsu WL, Yu KJ, Chien YC, Ko JY, Jian JJ, Tsou YA, Leu YS, Liao LJ, Chang YL, Wang CP, Wu JS, Hua CH, Lee JC, Yang TL, Hsiao CK, Wu MS, Tsai MH, Huang KK, Yu K, Jones K, Zhu B, Yeager M, Yu G, Lou PJ, Chen CJ, Hildesheim A; GEV-NPC group. Evaluation of Rare and Common Variants from Suspected Familial or Sporadic Nasopharyngeal Carcinoma (NPC) Susceptibility Genes in Sporadic NPC. Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1682-1686. doi: 10.1158/1055-9965.EPI-19-0007. Epub 2019 Jul 3. PMID: 31270100; PMCID: PMC6774819.
